Active substanceLactobacillus acidophilicLactobacillus acidophilic
Similar drugsTo uncover
  • Atzilact
    pills inwards 
  • Atzilact
    lyophilizate locally inwards the vagina. 
    FIRMA FERMENT, LLC     Russia
  • Atzilact
    suppositories the vagina. 
    FARMENT FIRM, LLC     Russia
  • Atzilact
    suppositories the vagina. 
    LANAFARM, LLC     Russia
  • Acylact, vaginal suppositories
    suppositories the vagina. 
  • Lactobacterin
    pills inwards 
  • LACTOJINAL®
    capsules the vagina. 
    Bezen Helskea SA     Belgium
  • Lactonorm
    capsules the vagina. 
  • Ecofemin®
    capsules the vagina. 
    Farma-Vinci A / S     Denmark
  • Dosage form: & nbsppills
    Composition:

    The preparation is a microbial mass of the living antagonistically active lactobacilli of the strains Lactobacillus plantarum 8P-A3, or L. plantarum 38, or L.fermentum 90T-C4 or L.fermentum 39, lyophilized in a culture medium with the addition of a protective sucrose-gelatin or sucrose- milk medium and compressed into tablets.

    One dose of the drug (tablet) contains at least 2 x 109 live lactobacilli.

    Excipients: starch - from 2 to 4%; talc - from 1 to 2%; Aerosil A300 or A380 - from 1 to 3%; lactose - from 2 to 10%.

    Description:

    Tablets of round shape with flat or slightly convex surfaces from yellowish-gray to beige, "marble" color is allowed.

    BIOLOGICAL PROPERTIES. The therapeutic effect of the drug is due to the antagonistic effect of lactobacillus in relation to pathogenic and opportunistic microorganisms, including staphylococci, enteropathogenic coliforms, proteins, shigella, which determines the corrective effect of the drug in cases of bacteriocenosis. The drug improves metabolic processes, prevents the formation of protracted forms of intestinal diseases, increases the nonspecific resistance of the body.

    Pharmacotherapeutic group:Eubiotic
    ATX: & nbsp

    G.01.A.X   Other antiseptics and antimicrobials for the treatment of gynecological diseases

    G.01.A.X.14   Lactobacilli

    Indications:

    Treatment of diseases of the gastrointestinal tract in children from 3 years of age and adults, accompanied by violations of normal microflora.

    Lactobacterin in tablets is intended for children from 3 years of age and adults.

    INDICATIONS FOR APPLICATION.

    In diseases of the gastrointestinal tract:

    - convalescents that have passed acute intestinal infections, with intestinal dysfunction or the isolation of pathogenic and opportunistic bacteria;

    - Somatic diseases complicated by dysbiosis caused by the use of antibiotics, chemotherapy and other causes;

    - complex treatment of weakened children with diseases of infectious and non-infectious etiology, accompanied by dysbiosis and atopic dermatitis;

    - chronic colitis of various etiology, including nonspecific ulcerative colitis.

    Contraindications:Not established, except for individual intolerance of the drug.
    Dosing and Administration:

    Lactobacterin in tablets is applied through the mouth, washed down with boiled water or milk, no later than; than 40-60 minutes before meals. Treatment is recommended to accompany the use of vitamins.

    Due to the high antibiotic resistance of lactobacilli, lactobacterin is allowed for antibiotic therapy.

    Lactobacterin in tablets is used in the following daily doses:

    - Children older than 3 years, depending on the severity of the disease for 2 to 5 doses 2 times a day;

    - adults - 5 - 10 doses 2-3 times a day.

    The course of treatment with lactobacterin for various diseases is:

    a) with prolonged and chronic course of dysentery, postdisenteric colitis, after treatment of convalescent after OCI, as well as with prolonged intestinal dysfunction of unknown etiology treatment - at least 4-6 weeks;

    b) with nonspecific ulcerative colitis, as well as chronic colitis and enterocolitis - up to 2 months;

    c) with dysbacteriosis of different etiology - 3-4 weeks.

    In the absence of the effect of using the drug for 2 weeks, it is necessary to re-examine the microflora of the gastrointestinal tract and correct it with other drugs, depending on the result obtained.

    To fix the obtained clinical effect or in the absence of complete normalization of microflora after the end of the course of treatment, in diseases that occur with relapses, repeated courses of treatment are advisable. In these cases, prior to the appointment of the drug, a re-examination of the microflora is necessary. Supportive doses of the drug (half the daily dose) are prescribed after 2-3 weeks for 1-1.5 months.

    Side effects:There was no reaction to the administration of the drug.
    Form release / dosage:Pills.
    Packaging:For 20 tablets in a vial. 5 or 10 bottles in a pack with instructions for use.
    Storage conditions:

    The drug is stored (inaccessible to children) and transported in accordance with SP 3.3.2.1248-03 at a temperature of no higher than 10 ° C.

    Not suitable for use:

    - the integrity of the packaging is broken (cracked bottles),

    - without marking,

    - with changed physical properties (discoloration, wrinkling of the tablet), in the presence of inclusions,

    - expired.

    Shelf life:1 year.
    Terms of leave from pharmacies:Without recipe
    Registration number:LS-002096
    Date of registration:13.10.2006
    Expiration Date:13.10.2011
    The owner of the registration certificate:MICROGEN FGUP Scientific and Production Association MICROGEN FGUP Scientific and Production Association Russia
    Manufacturer: & nbsp
    Information update date: & nbsp10.02.2018
    Illustrated instructions
      Instructions
      Up